Author:
Somlo G,Simpson J F,Frankel P,Chow W,Leong L,Margolin K,Morgan R,Raschko J,Shibata S,Forman S,Kogut N,McNamara M,Molina A,Somlo E,Doroshow J H
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy Jr PL, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM (1997) High-dose chemotherapy with autologous hematopoietic support for breast cancer in North America. J Clin Oncol 15: 1870–1879
2. Bitran JD, Samuels B, Trujillo Y, Klein L, Schroeder L, Martinec J (1996) Her-2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy. Clin Cancer Res 2: 1509–1513
3. Bonadonna G, Zambetti M, Valagussa P (1995) Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten year results. JAMA 273: 542–547
4. Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE (1992) Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer 69: 448–452
5. Cox DR (1972) Regression Models and Life Tables. J R Statist Soc B 34: 187–220
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献